Population Pharmacokinetics of Olmesartan Following Oral Administration of its Prodrug, Olmesartan Medoxomil
- 作者Dr Kazutaka Yoshihara, Yuying Gao, Hiroshi Shiga, D. Russell Wada, Masafumi Hisaoka
- 卷第44卷
- 期第12期
- 文件大小1524.43KB
- 发表时间2005-12
- DOI10.2165/00003088-200544120-00011
- 页码1329-1342
Clinical Pharmacokinetics of CyclophosphamideLouise B. Grochow,Dr Michael Colvin · Clinical Pharmacokinetics · 1979
Clinical Pharmacokinetics of CyclophosphamideDr Malcolm J. Moore · Clinical Pharmacokinetics · 1991
Methods in Clinical Pharmacology || Pharmacokinetics of cyclophosphamide (Endoxan): The balance of cyclophosphamide metabolites in the mouseRietbrock, Norbert; Woodcock, Barry G.; Neuhaus, Günter · 1980
Analysis of cyclophosphamide and carboxyethylphosphoramide mustard enantiomers in human plasma and application to clinical pharmacokineticsCastro, Francine Attié de; Scatena, Gabriel dos Santos; Cass, Quézia Bezerra; Simões, Belinda Pinto; Lanchote, Vera Lucia · Journal of Chromatography B · 2014
The importance of both <i>CYP2C19</i> and <i>CYP2B6</i> germline variations in cyclophosphamide pharmacokinetics and clinical outcomes.Helsby, N.A.; Yong, M.; van Kan, M.; de Zoysa, J.R.; Burns, K.E. · British Journal of Clinical Pharmacology · 2019